SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 84 filers reported holding SYNAGEVA BIOPHARMA CORP in Q4 2013. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $7,254,000 | +34.5% | 74,379 | +28.0% | 0.01% | +42.9% |
| Q4 2014 | $5,393,000 | +34.4% | 58,122 | -0.4% | 0.01% | +16.7% |
| Q3 2014 | $4,014,000 | -34.5% | 58,355 | -0.1% | 0.01% | -25.0% |
| Q2 2014 | $6,125,000 | +29.6% | 58,441 | +2.6% | 0.01% | +14.3% |
| Q1 2014 | $4,725,000 | +38.2% | 56,949 | +7.8% | 0.01% | +40.0% |
| Q4 2013 | $3,418,000 | +11.6% | 52,816 | +9.3% | 0.01% | 0.0% |
| Q3 2013 | $3,062,000 | +62.3% | 48,310 | +7.5% | 0.01% | +66.7% |
| Q2 2013 | $1,887,000 | – | 44,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
| BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
| SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
| Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
| Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
| ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
| PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
| FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
| Tradeworx Inc. | 2,936 | $308,000 | 0.25% |